| ［1］ |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology［J］. Genet Med, 2015,17（5）:405⁃424. doi: 10.1038/gim.2015.30.
|
| ［2］ |
中国医师协会医学遗传医师分会, 中国妇幼保健协会出生缺陷与分子遗传分会, 上海市医师协会临床遗传专业委员会, 等. 遗传病基因变异全外显子组测序技术规范化应用专家共识［J］. 中华医学遗传学杂志, 2025,42（1）:11. doi: 10.3760/cma.j.cn511374⁃20240723⁃00404.
|
| ［3］ |
Dadi H, Jones TA, Merico D, et al. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 （CARD11）［J］. J Allergy Clin Immunol, 2018,141（5）:1818⁃1830. doi: 10.1016/j.jaci.2017.06.047.
|
| ［4］ |
Ma CA, Stinson JR, Zhang Y, et al. Germline hypomorphic CARD11 mutations in severe atopic disease［J］. Nat Genet, 2017,49（8）:1192⁃1201. doi: 10.1038/ng.3898.
|
| ［5］ |
Hirota T, Takahashi A, Kubo M, et al. Genome⁃wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population［J］. Nat Genet, 2012,44（11）:1222⁃1226. doi: 10.1038/ng.2438.
|
| ［6］ |
Charvet E, Bourrat E, Hickman G, et al. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant⁃negative CARD11 variant［J］. Clin Exp Dermatol, 2021,46（7）:1334⁃1335. doi: 10.1111/ced.14686.
|
| ［7］ |
Gualdi G, Lougaris V, Amerio P, et al. Prurigo⁃like atopic dermatitis in a child with CARD11⁃associated severe combined immunodeficiency successfully treated with dupilumab［J］. Pediatr Dermatol, 2024,41（1）:158⁃159. doi: 10.1111/pde.15453.
|
